ID   TMCC-2
AC   CVCL_6736
DR   BTO; BTO_0006336
DR   Wikidata; Q54972688
RX   PubMed=1888705;
RX   PubMed=1890355;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=1888705; PubMed=1890355).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
CH   CVCL_6737 ! TMCC-2.U
//
RX   PubMed=1890355;
RA   Iwabuchi, Hiroshi
RA   Nagata, Junko
RA   Sakunaga, Hodaka
RA   Sakamoto, Masaru
RA   Okabe, Kazuhiro
RA   Nutahara, Yuuichi
RA   Satou, Hiromi
RA   Negishi, Yoshiyuki
RA   Suzuta, Tatsuo
RA   Sugita, Michio
RA   Sugishita, Tadashi
RA   Tenjin, Yoshio
RT   "Establishment and characterization of endometrial clear cell
RT   carcinoma cell line (TMCC-2).";
RL   Nihon Sanka Fujinka Gakkai Zasshi 43:771-778(1991).
//
RX   PubMed=1888705;
RA   Iwabuchi, Hiroshi
RA   Nakaya, Hitsohi
RA   Sakunaga, Hodaka
RA   Nagata, Junko
RA   Sakamoto, Masaru
RA   Okabe, Kazuhiro
RA   Negishi, Yoshiyuki
RA   Sugita, Michio
RA   Sugishita, Tadashi
RA   Tenjin, Yoshio
RT   "Establishment and characterization of endometrial undifferentiated
RT   carcinoma cell line (TMCC-2.U).";
RL   Hum. Cell 4:58-62(1991).
//